Logo-jcvtr

J Cardiovasc Thorac Res. 2014;6(3): 153-162. doi: 10.15171/jcvtr.2014.004
PMID: 25320662        PMCID: PMC4195965

Original Article

Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients

Alexander E. Berezin 1 * , Alexander A. Kremzer 2, Tatyana A. Samura 2, Tatyana A. Berezina 3, Yulia V. Martovitskaya 4

Cited by CrossRef: 6


1- Peyter A, Armengaud J, Guillot E, Yzydorczyk C. Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches. IJMS. 2021;22(13):6667 [Crossref]
2- Berezin A. Does serum uric acid play a protective role against tissue damage in cardiovascular and metabolic diseases?. Ann Clin Hypertens. 2016;1(1):039 [Crossref]
3- Bonora B, Morieri M, Marassi M, Cappellari R, Avogaro A, Fadini G. Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells. Diabetologia. 2023;66(12):2346 [Crossref]
4- Marassi M, Fadini G. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023;22(1) [Crossref]
5- Berezin A. Endothelial progenitor cells dysfunction and impaired tissue reparation: The missed link in diabetes mellitus development. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;11(3):215 [Crossref]
6- Santilli F, D'Ardes D, Davì G. Oxidative stress in chronic vascular disease: From prediction to prevention. Vascular Pharmacology. 2015;74:23 [Crossref]
7- Berezin A. Serum uric acid as a metabolic regulator of endothelial function in heart failure. Arch Clin Hypertens. 2017;3(1):027 [Crossref]